Verrica Pharmaceuticals (VRCA) Receivables - Net (2023 - 2025)
Verrica Pharmaceuticals (VRCA) has 3 years of Receivables - Net data on record, last reported at $5.3 million in Q4 2025.
- For Q4 2025, Receivables - Net rose 10858.33% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, up 10858.33%, while the annual FY2025 figure was $5.3 million, 10858.33% up from the prior year.
- Receivables - Net reached $5.3 million in Q4 2025 per VRCA's latest filing, down from $7.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $10.0 million in Q2 2024 and bottomed at $48000.0 in Q4 2024.
- Average Receivables - Net over 3 years is $5.8 million, with a median of $5.6 million recorded in 2025.
- Peak YoY movement for Receivables - Net: crashed 98.87% in 2024, then skyrocketed 10858.33% in 2025.
- A 3-year view of Receivables - Net shows it stood at $4.2 million in 2023, then plummeted by 98.87% to $48000.0 in 2024, then surged by 10858.33% to $5.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $5.3 million in Q4 2025, $7.0 million in Q3 2025, and $9.2 million in Q2 2025.